Immunotargeting of Functional Nanoparticles for MRI detection of Apoptotic Tumor Cells
Source abstract
Abstract
Hybrid MRI nanoprobes, immunotargeted to the La ribonucleoprotein, which becomes available for binding in the cytoplasm of post-apoptotic permeable cells, are designed for the improved detection of apoptotic tumor cells. The high level of specificity achieved through the use of an optimal polyethyleneglycol interlayer makes them excellent candidates for the in vivo detection of intratumoral apoptosis.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (49)
Show source-provided references
1. 10.1038/nrc228910.1038/nrc2289 ↗
2. 10.1016/S0959-8049(02)00395-710.1016/S0959-8049(02)00395-7 ↗
3. 10.1021/nl052469410.1021/nl0524694 ↗
4. 10.1021/ja057712f10.1021/ja057712f ↗
5. 10.1021/nl060694v10.1021/nl060694v ↗
6. 10.1162/15353500232016276910.1162/153535002320162769 ↗
7. 10.1038/nm1101-124110.1038/nm1101-1241 ↗
8. 10.1002/smll.20070084710.1002/smll.200700847 ↗
9. 10.1016/j.jmmm.2005.01.06410.1016/j.jmmm.2005.01.064 ↗
10. 10.1002/anie.20060286610.1002/anie.200602866 ↗
11. 10.1161/CIRCULATIONAHA.106.64638010.1161/CIRCULATIONAHA.106.646380 ↗
12. 10.1080/1040843070177668010.1080/10408430701776680 ↗
13. 10.1007/s00395-008-0710-710.1007/s00395-008-0710-7 ↗
14. 10.1038/nm146710.1038/nm1467 ↗
15. 10.1021/nl071099b10.1021/nl071099b ↗
16. 10.1038/nature0416510.1038/nature04165 ↗
17. 10.1021/ja026501x10.1021/ja026501x ↗
18. 10.1021/ja051833y10.1021/ja051833y ↗
19. 10.1002/adma.20040154510.1002/adma.200401545 ↗
20. 10.1021/cm05006010.1021/cm050060 ↗
21. 10.1038/nmat125110.1038/nmat1251 ↗
22. Belhocine T. · Clin. Cancer Res. · 2002 · 8 · 2766
23. 10.1021/nl062226r10.1021/nl062226r ↗
24. 10.1021/nl070126v10.1021/nl070126v ↗
25. 10.1016/j.nucmedbio.2007.06.01410.1016/j.nucmedbio.2007.06.014 ↗
26. 10.1177/15330346040030010310.1177/153303460400300103 ↗
27. 10.1158/1078-0432.CCR-07-092210.1158/1078-0432.CCR-07-0922 ↗
28. 10.1158/1078-0432.CCR-07-096410.1158/1078-0432.CCR-07-0964 ↗
29. 10.1016/j.biomaterials.2006.03.03910.1016/j.biomaterials.2006.03.039 ↗
30. 10.1021/la800720610.1021/la8007206 ↗
31. 10.1080/1061186070153958410.1080/10611860701539584 ↗
32. B.Thierry F.Al‐Ejeh M. P.Brown H. J.Griesser Manuscript in preparation.
33. 10.1002/chem.20060031310.1002/chem.200600313 ↗
34. 10.1021/ja046480210.1021/ja0464802 ↗
35. 10.1016/S0956-5663(00)00104-410.1016/S0956-5663(00)00104-4 ↗
36. 10.1021/la034974r10.1021/la034974r ↗
37. 10.1038/nnano.2007.43310.1038/nnano.2007.433 ↗
38. 10.1021/nl070363y10.1021/nl070363y ↗
39. 10.1073/pnas.060861110410.1073/pnas.0608611104 ↗
40. 10.1038/nnano.2008.3010.1038/nnano.2008.30 ↗
41. 10.1016/j.biomaterials.2007.12.03710.1016/j.biomaterials.2007.12.037 ↗
42. Gaumet M. · Eur. J. Pharm. Biopharm. · 2007
43. 10.1002/adma.20070176010.1002/adma.200701760 ↗
44. 10.1163/15685620232025393810.1163/156856202320253938 ↗
45. 10.1038/nbt72010.1038/nbt720 ↗
46. 10.1038/nprot.2007.37710.1038/nprot.2007.377 ↗
47. 10.1021/ja056299910.1021/ja0562999 ↗
48. The dopamine‐stabilized nanoparticle suspension (primary size distribution about 10‐15 nm in diameter) showed very poor retention in the magnetic column.
49. 10.1016/j.biomaterials.2004.07.02310.1016/j.biomaterials.2004.07.023 ↗